Attitudes toward fertility and fertility preservation in women with glioma

Neuro-oncology Practice
Rachel K StinerMitchell Rosen

Abstract

No studies have examined the fertility priorities of women undergoing treatment for their glioma. Glioma patients frequently undergo chemotherapy as part of their treatment; however, it is unknown whether patients truly are aware of its possible effects on their fertility. Our objective was to assess the fertility priorities of glioma patients and ascertain whether female glioma patients are being effectively counseled on the effects of chemotherapy on their fertility prior to beginning treatment. The sample was composed of female patients from the Neuro-oncology clinic of the University of California, San Francisco. Participants completed a cross-sectional survey between October 2010 and December 2013 exploring their attitudes toward fertility and their experience with fertility counseling prior to chemotherapy initiation. Seventy-two women completed the survey. Analysis of the survey results showed that 30% of women receiving chemotherapy reported having a discussion regarding fertility preservation prior to beginning treatment. Of those who reported having this discussion, 80% were aware that chemotherapy could negatively affect their fertility. Many women reported that while fertility preservation was not important to them ...Continue Reading

References

Jan 1, 1983·Journal of Psychosomatic Research·A M O'MooreM E Carruthers
Feb 8, 1995·International Journal of Cancer. Journal International Du Cancer·R SankilaL Teppo
Jan 15, 1998·Social Science & Medicine·A L Greil
May 14, 1998·British Journal of Cancer·J D BrierleyM Pintilie
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J GoodwinN Hood
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeEric P Winer
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 16, 2005·CA: a Cancer Journal for Clinicians·Beth SimonCarolyn D Runowicz
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B ThewesM L Friedlander
Feb 24, 2006·The Journal of Clinical Endocrinology and Metabolism·Wassim ChemaitillyCharles A Sklar
Jul 5, 2006·Journal of the National Cancer Institute·Charles A SklarLeslie L Robison
Oct 19, 2006·Journal of the National Cancer Institute·Lisa B SignorelloJohn D Boice
Jan 20, 2012·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Christine DuffyKay Dickersin
May 31, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·V L PeddieS Bhattacharya
Jul 4, 2012·Journal of Cancer Survivorship : Research and Practice·Erin Ebbel NiemasikMitchell Rosen
May 15, 2013·Reproductive Biomedicine Online·Jayeon KimJennifer E Mersereau
Aug 7, 2013·Journal of Psychosomatic Obstetrics and Gynaecology·Leoni A LouwéAnne M Stiggelbout
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark R GilbertMinesh P Mehta
Oct 1, 2012·Practical Radiation Oncology·Clement K GwedeGwendolyn P Quinn
Oct 21, 2015·Critical Reviews in Oncology/hematology·Maria VassilakopoulouAmanda Psyrri
Apr 7, 2016·The New England Journal of Medicine·Jan C BucknerWalter J Curran
Jul 13, 2016·International Journal of Clinical Oncology·Akiko AbeMinoru Irahara

❮ Previous
Next ❯

Citations

Feb 16, 2020·Journal of Neuro-oncology·Taylor NordanPietro Bortoletto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.